Peter Parsonson
About Peter Parsonson
Peter Parsonson serves as the Head of US Regulatory Affairs at KalVista Pharmaceuticals, Inc., a position he has held since 2021. He has extensive experience in regulatory affairs, having worked in various roles at companies such as Sirion Therapeutics, Alcon Laboratories, and Aeglea BioTherapeutics.
Work at KalVista Pharmaceuticals
Peter Parsonson serves as the Head of US Regulatory Affairs at KalVista Pharmaceuticals, Inc. since 2021. In this role, he oversees regulatory strategy and compliance for the company's operations in the United States. His responsibilities include managing submissions to regulatory agencies and ensuring that the company's products meet all necessary regulatory requirements.
Previous Experience in Regulatory Affairs
Peter Parsonson has extensive experience in regulatory affairs across various organizations. He worked at Sirion Therapeutics as Senior Manager of Regulatory Operations from 2007 to 2009. He then joined Alcon Laboratories, Inc. as Associate Director of Pharmaceutical Regulatory Affairs from 2009 to 2013. Following that, he held positions at Aeglea BioTherapeutics, first as Director of Regulatory Affairs for six months in 2018, and then as Sr. Director of Regulatory Affairs from 2019 to 2021. Additionally, he served as Director and then Senior Director of Global Regulatory Affairs at Smith & Nephew, Inc. from 2013 to 2017.
Educational Background
Peter Parsonson studied Chemistry at the University of North Georgia, where he earned a Bachelor of Science degree from 1987 to 1991. He furthered his education at the Georgia Institute of Technology, obtaining a Master of Science degree in Chemistry from 1993 to 1996. His academic background provides a strong foundation for his career in regulatory affairs.
Career Development and Roles
Peter Parsonson's career spans over two decades in the pharmaceutical and biotechnology sectors. He began his career as a scientist at Solvay Pharmaceuticals from 1996 to 1999. He later served as Chief Operating Officer at Roskamp Institute from 2004 to 2007. His roles have progressively advanced, leading to senior positions in regulatory affairs at various companies, demonstrating his expertise in navigating complex regulatory environments.